Trial Profile
Clinical Trials Insight: 700019539
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2006
Price :
$35
*
At a glance
- Drugs 1018-ISS (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Dynavax Technologies
- 07 Dec 2006 New trial record.